Pacemakers

Abstract Background and Objectives: COVID-19 pandemic severely impacted public health services worldwide, determining a significant decrease of elective cardiovascular (CV) procedures, especially in patients with associated chronic diseases such as diabetes mellitus (DM). Materials and Methods: This study was first started in 2019 in the western of Romania, to analyze the differences regarding the implantations of intra-cardiac devices such as permanent pacemakers (PPM), cardiac resynchronization therapy (CRT), or implantable cardioverter-defibrillators (ICD) in 351 patients with and without DM and the situation was reanalyzed at the end of 2020. Results: of the first 351 patients with and without DM. 28.20% of these patients had type 2 DM (p = 0.022), exceeding more than twice the prevalence of DM in the general population (11%). Patients with DM were younger (p = 0.022) and required twice as often CRT (p = 0.002) as non-diabetic patients. The state of these procedures was reanalyzed at the end of 2020, a dramatic decrease of all new device implantations being observed, both in non-diabetic and in patients with type 2 DM (79.37%, respectively 81.82%). Conclusions: COVID-19 pandemic determined a drastic decrease, with around 75% reduction of all procedures of new intra-cardiac devices implantation, both in non-diabetics, this activity being reserved mostly for emergencies. University of Medicine and Pharmacy “Victor Babes” Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania摘要 背景与目的：新型冠状病毒肺炎（COVID-19）大流行严重冲击全球公共卫生服务体系，导致择期心血管（cardiovascular, CV）手术量显著下降，尤以合并糖尿病（diabetes mellitus, DM）等慢性疾病的患者群体为甚。 材料与方法：本研究于2019年在罗马尼亚西部启动，旨在分析351例合并与未合并糖尿病患者的心脏内植入器械植入差异，涉及手术类型包括永久性心脏起搏器（permanent pacemakers, PPM）植入、心脏再同步治疗（cardiac resynchronization therapy, CRT）以及植入式心律转复除颤器（implantable cardioverter-defibrillators, ICD）植入，并于2020年末对相关情况开展二次分析。 结果：在首批纳入的351例合并与未合并糖尿病的患者中，28.20%为2型糖尿病患者（p=0.022），其糖尿病患病率超过普通人群（11%）的两倍。合并糖尿病的患者年龄更小（p=0.022），且需接受心脏再同步治疗的比例是非糖尿病患者的两倍（p=0.002）。2020年末对上述手术情况进行二次分析时，观察到非糖尿病患者与2型糖尿病患者的所有新增心脏器械植入手术量均出现大幅下降，降幅分别为79.37%与81.82%。 结论：新型冠状病毒肺炎（COVID-19）大流行导致所有新增心脏内器械植入手术量大幅缩减，整体降幅约达75%，此类手术无论是针对非糖尿病患者还是糖尿病患者，此后大多仅保留用于急诊病例。 罗马尼亚蒂米什瓦拉维克多·巴贝什医科大学，E·穆尔吉广场2号，300041 蒂米什瓦拉